| Date | Title | Description |
| 07.10.2024 | Operationalizing Innovative Biomarkers to Support Evolving Therapeutic and Diagnostic Landscape for Neurodegenerative Diseases, Upcoming Webinar Hosted by Xtalks | www.labcorp.com
In this free webinar, learn about the rapidly evolving landscape of Alzheimer's disease therapy development and treatment. Attendees will gain insights into the key considerations for various platforms and strategies to inco... |
| 03.10.2024 | Considerations on the Evolving Testing Requirements for Environmental Fate Studies, Upcoming Webinar Hosted by Xtalks | www.labcorp.com
In this free webinar, learn how the regulatory landscape is changing with a shift to evaluate more complex chemicals. Attendees will learn how the nature of these complex chemical substances presents challenges in performing... |
| 22.08.2024 | PreciseDx's $20.7 Million Boost: A New Dawn for AI in Cancer Diagnostics | In the world of oncology, every second counts. PreciseDx, a trailblazer in cancer diagnostics, has just secured a significant lifeline. The company raised $20.7 million in Series B funding, bringing its total funding to $31.5 million. This ... |
| 21.08.2024 | PreciseDx Raises $20.7M for AI-Powered Cancer Risk Assessments | What You Should Know:
– PreciseDx, a pioneering company in oncology diagnostics utilizing artificial intelligence (AI) raises $20.7M in Series B funding led by Eventide Asset Management with participation from Labcorp, Quest Diagnostics, Ge... |
| 31.07.2024 | Pendo Accelerates AI Roadmap with Acquisition of Customer Intelligence Platform Zelta AI | Announces strong early adoption of AI features now available across the Pendo One platform
RALEIGH, N.C. and NEW YORK, July 31, 2024 /PRNewswire/ -- Pendo, the all-in-one product experience platform, today announced that it has acquired Zel... |
| 17.05.2024 | Revolutionizing Obesity Treatment with Precision Medicine | Phenomix Sciences, a cutting-edge biotechnology company, has secured a whopping $7.8 million in funding to accelerate the adoption of precision medicine in the treatment of obesity. This influx of capital, including $5.5 million in Series A... |
| 16.05.2024 | Phenomix Sciences Raises $7.8M to Acclerate Obesity Precision Medicine Adoption | What You Should Know:
– Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, has secured $5.5 million in Series A funding from new investors, DexCom, Inc. and La... |
| 14.03.2024 | Global Medical Device Outsourcing Market Forecast 2024-2033 – Market Size, Drivers, Trends, And Competitors | Medical Device Outsourcing Global Market Report 2024 : Market Size, Trends, And Global Forecast 2024-2033
The Business Research Company's Medical Device Outsourcing Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2... |
| 12.03.2024 | Clinical Laboratory Services Market Projected to Reach $286.77 Billion by 2030, Driven by Advances in Disease Diagnosis and Increasing Geriatric Population | - |
| 12.03.2024 | Durham’s Fortrea to divest two businesses for $345M | Fortrea, a global contract research organization (CRO) that was spun off of Burlington-based Labcorp in 2023, will divest two of its businesses to focus more on supporting clinical drug development in phases 1 through 4.
Fortrea, headquarte... |
| 14.11.2023 | Ovia Health Launches New Fertility, Family-Building Offering | About one in six people globally battle infertility, according to the World Health Organization. That’s why Ovia Health by Labcorp is launching a new fertility and family-building benefit for employers and health plans, the company announce... |
| 27.09.2023 | FemTech: Evvy Raises $14M to Revolutionize Precision Women’s Healthcare | What You Should Know:
Evvy, a female-founded startup unlocking precision women’s healthcare through biomarker discovery, announced today the closing of a $14 million Series A funding round led by Left Lane Capital.
The round also includes G... |
| 07.08.2023 | New Diagnostics and Emerging Biomarkers for Alzheimer’s Disease, Upcoming Webinar Hosted by Xtalks | Xtalks Life Science Webinars This webinar will illuminate recent advancements, discuss the establishment of the ATN research framework and delve into how this new paradigm is revolutionizing the understanding and treatment of Alzheimer’s di... |
| 13.06.2023 | Non-Invasive Approaches to NAFLD/NASH Drug Development, Upcoming Webinar Hosted by Xtalks | Gain valuable knowledge about the latest NASH biomarkers and their practical applications in clinical settings.
TORONTO (PRWEB) June 13, 2023
This webinar will focus on non-invasive approaches to NAFLD/NASH drug development. During the webi... |
| 09.06.2023 | Proteomedix set for growth | |
| 01.02.2023 | The 11th Annual Lake Nona Impact Forum Returns to Address Health Innovation in the New Reality | Dr. Sanjay Gupta speaking at the 2022 Lake Nona Impact Forum in Lake Nona, Orlando, Florida. “Since its inception 11 years ago, Lake Nona Impact Forum’s North Star is to inspire human potential through health and wellbeing innovation,” said... |
| 17.10.2022 | Redi.Health Sees Tremendous Growth for Platform that Empowers Patients to Understand, Manage and Track their Health with Digital Support | Technology is revolutionizing healthcare, which is an industry that is long overdue for innovation. Redi.Health is helping simplify an extremely complex industry so patients can take more control of their healthcare journey.
COLUMBUS, Ohio ... |
| 13.10.2022 | NfL in Real-World Clinical Settings, Upcoming Webinar Hosted by Xtalks | Clinicians are beginning to use NfL and are learning about how it can provide useful and important information for patient care.
TORONTO (PRWEB) October 13, 2022
Neurofilament light chain (NfL) protein has been well studied in a broad array... |
| 14.07.2022 | Connecticut Department Of Public Health Provides Update On Monkeypox; Case Count Now Up To 11 | Press Releases
07/14/2022 Connecticut Department Of Public Health Provides Update On Monkeypox; Case Count Now Up To 11
FOR IMMEDIATE RELEASE: July 14, 2022
CONTACT: Chris Boyle, Director of Communications
(860) 706-9654 – christopher.boyle... |
| 12.07.2022 | Redi.Health Collaborates with Labcorp to Seamlessly Connect Patients and Providers | This collaboration is a significant steppingstone for the future of how patients will be able to manage their health and connect to pharmaceutical stakeholders.
COLUMBUS, Ohio (PRWEB) July 12, 2022
Today, Redi.Health, provider of health man... |
| 29.04.2022 | Teladoc’s 2022 Q1 earnings reveal a slowdown—but its chronic care business could rev it back up | The news: Teladoc reported that its Q1 year-over-year revenue grew 25% from $453.7 million in 2021 to $565.4 million in 2022.
However, Teladoc execs lowered their expected revenue for the full 2022 year: Now they expect $2.4 billion to $2.5... |
| 21.04.2022 | Portfolio Company Xcellbio expands Labcorp Collaboration for Cell & Gene Therapies | Xcell Biosciences, Inc. (“Xcellbio”), a leading developer of cell and gene therapy technologies has expanded its collaboration with Labcorp to advance critical work that helps clients effectively bring innovative cell and gene therapies to ... |
| 09.04.2022 | Constellation Brands and Murphy Oil Raise Payouts in a Quiet Week for Dividend Hikes | Constellation Brands and Murphy Oil were among the small number of companies that declared dividend increases this week.
In addition, Laboratory Corp. of America Holdings (ticker: LH) initiated a quarterly dividend of 72 cents a share. Labc... |
| 01.04.2022 | Labcorp & Medidata to Co-Develop Digital Biomarkers & Expand Decentralized Clinical Trials | What You Should Know:
- Medidata, a Dassault Systèmes company, today announced that Labcorp, a leading global life sciences company, has selected Medidata’s technology platform to extend their 14-year partnership, the foundation of their in... |
| 22.02.2022 | Tenth Annual Lake Nona Impact Forum Convenes Health And Wellbeing Thought Leaders In Orlando, Florida | Deepak Chopra speaks during the Lake Nona Impact Forum “There’s no doubt we live in a different world since the arrival of COVID-19,” said Impact Forum Co-Founder Gloria Caulfield. “This year’s Impact Forum is critical as we gather some of ... |
| 10.02.2022 | Laboratory of America : Labcorp Announces 2021 Fourth Quarter and Full-Year Results Company Provides 2022 Guidance and Longer-Term Outlook (2022-2024) - Form 8-K | Labcorp Announces 2021 Fourth Quarter and Full-Year Results
Company Provides 2022 Guidance and Longer-Term Outlook (2022-2024)
•Revenue: Q4 of $4.1 billion, versus $4.5 billion last year; Full year of $16.1 billion, versus $14.0 billion las... |
| 03.02.2022 | A Review of Current Biomarkers for Alzheimer’s Disease, Upcoming Webinar Hosted by Xtalks | The featured speakers will discuss the positives and challenges in testing for these individual markers and how these tests might be used in clinical trials now and in the clinic in the future.
TORONTO (PRWEB) February 03, 2022
It seems tha... |
| 15.11.2021 | Labcorp Opens New Integrated Laboratory, Strengthens Bioanalytical Services In Asia-Pacific | SINGAPORE, Nov. 15, 2021 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, today announced the expansion of its global offerings and its footprint in the Asia-Pacific (APAC) region with the opening of a new, integr... |
| 04.11.2021 | Immuno-Oncology – Converting Cancer to a “Chronic Disease,” Upcoming Webinar Hosted by Xtalks | This subpopulation of patients tends to lead a life with cancer as a chronic disease rather than a terminal illness.
TORONTO (PRWEB) November 04, 2021
The treatment of a cancer patient with immunotherapies offers unparalleled innovation tha... |
| 03.11.2021 | Uncovering the Regulatory Advice Affecting OECD 443 Study Design and the Impact on Your Ongoing and Future Studies, Upcoming Webinar Hosted by Xtalks | These recommendations have resulted in the necessity to amend the design of ongoing and planned studies ultimately affecting resources, time and cost of a study which was already complex and costly.
TORONTO (PRWEB) November 03, 2021
The Ext... |
| 02.11.2021 | Addressing Low Detection of Chronic Kidney Disease in At-Risk Patients, Upcoming Webinar Hosted by Xtalks | Hear first-hand from a patient on how early detection can improve outcomes for patients and their families.
TORONTO (PRWEB) November 02, 2021
One in three adults in the US have risk factors for developing CKD, a gradual loss of kidney funct... |
| 28.10.2021 | Labcorp Announces 2021 Third Quarter Results Company Raises Full-Year Guidance - Form 8-K | Labcorp Announces 2021 Third Quarter Results
Company Raises Full-Year Guidance
•Revenue: Q3 of $4.1 billion, versus $3.9 billion last year
•Diluted EPS: Q3 of $6.05, versus $7.17 last year
•Adjusted EPS: Q3 of $6.82, versus $8.41 last year
... |
| 04.10.2021 | FDA authorizes Labcorp’s at-home test kit for Covid-19, flu | Pixel received emergency use authorization for an at-home combined Covid-19 and flu test kit. Credit: Labcorp
The Food and Drug Administration gave the green light to Labcorp’s at-home combination test for Covid-19 and influenza A and B. Th... |
| 02.09.2021 | Labcorp : Raises Minimum Hourly Wage to $15 Per Hour | Labcorp (NYSE: LH), a leading global life sciences company, today announced it has increased the minimum hourly wage for United States (U.S.)-based, non-union employees to $15, effective September 2021.
This press release features multimedi... |
| 16.08.2021 | M&A: Labcorp Acquires Ovia Health to Expand Women’s Health Capabilities | What You Should Know:
– Labcorp has announced the acquisition of femtech startup Ovia Health, a digital health platform used by millions of women seeking information and support with family planning, pregnancy, and parenting. Financial deta... |
| 16.08.2021 | Use of Large Real-World Datasets to Improve Practice Guidelines and Clinical Study Designs in Metabolic Diseases, Upcoming Webinar Hosted by Xtalks | Practically speaking, these data can provide insights to help drive improvements in healthcare delivery.
TORONTO (PRWEB) August 16, 2021
Over the last decade, the collection and analysis of personal medical data has expanded and has been ap... |
| 29.07.2021 | Laboratory of America : Labcorp Announces 2021 Second Quarter Results Company Raises Full Year Guidance (Form 8-K) | Labcorp Announces 2021 Second Quarter Results
Company Raises Full Year Guidance
•Revenue: Q2 of $3.8 billion, versus $2.8 billion last year
•Diluted EPS: Q2 of $4.76, versus $2.37 last year
•Adjusted EPS: Q2 of $6.13, versus $2.57 last year... |
| 22.07.2021 | Biospectal concludes a $4.3M seed investment round | |
| 30.06.2021 | Accelerating Clinical Trials with Streamlined Project Management Methodology, Upcoming Webinar Hosted by Xtalks | By developing a platform that answers the question of “what do I do next”, project managers—along with entire study teams can become more proactive and effective, while keeping studies on track.
TORONTO (PRWEB) June 30, 2021
Clinical trial ... |
| 28.06.2021 | Modernizing Neuroscience Clinical Trials Using a Virtual Framework: A Perspective on Endpoint Measurement and Best Practices, Upcoming Webinar Hosted by Xtalks | The strengths of this framework as well as the challenges and necessary scientific and operational considerations will be presented.
TORONTO (PRWEB) June 28, 2021
The global pandemic has accelerated the need to modernize clinical trials via... |
| 04.05.2021 | GENFIT
GENFIT : announces the launch by Labcorp of NASHnext A Novel Noninvasive Diagnostic Test Powered by GENFIT's NIS4 Technology to Identify Patients with At-Risk NASH | Lille, France; Cambridge, MA - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases, today announced the launch of NASHnext, a novel, nonin... |
| 29.04.2021 | Laboratory of America : Labcorp Announces 2021 First Quarter Results Company Raises Full Year Guidance | Labcorp Announces 2021 First Quarter Results
Company Raises Full Year Guidance
•Revenue: Q1 of $4.2 billion, up from $2.8 billion last year
•Diluted EPS: Q1 of $7.82, up from ($3.27) last year
•Adjusted EPS: Q1 of $8.79, up from $2.37 last ... |
| 29.04.2021 | LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory of America : Labcorp Announces 2021 First Quarter Results Company Raises Full Year Guidance | Labcorp Announces 2021 First Quarter Results
Company Raises Full Year Guidance
•Revenue: Q1 of $4.2 billion, up from $2.8 billion last year
•Diluted EPS: Q1 of $7.82, up from ($3.27) last year
•Adjusted EPS: Q1 of $8.79, up from $2.37 last ... |
| 30.03.2021 | MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform | Net Cash Used in Operating Activities (Total Cash Burn) of $24.2 million USD ($30.5 million CAD) for year ended December 31, 2020
NEW YORK, March 30, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. ("MindMed" or the "Compan... |
| 30.03.2021 | MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform | Net Cash Used in Operating Activities (Total Cash Burn) of $24.2 million USD ($30.5 million CAD) for year ended December 31, 2020
NEW YORK, March 30, 2021 /CNW/ -- Mind Medicine (MindMed) Inc. ("MindMed" or the "Company"... |
| 23.03.2021 | Labcorp Business Update | BURLINGTON, N.C.--(BUSINESS WIRE)--Mar 23, 2021--
Labcorp (NYSE: LH), a leading life sciences company, today issued the following statement:
Labcorp continues to make progress executing our strategy and capitalizing on the power of our diag... |
| 23.03.2021 | Dr. Marcia Eisenberg, Chief Scientific Officer of Labcorp Diagnostics, Named a Healthcare Businesswoman’s Association Luminary | BURLINGTON, N.C.--(BUSINESS WIRE)--Mar 23, 2021--
Labcorp (NYSE: LH), a leading global life sciences company, today announced that Marcia Eisenberg, Ph.D., chief scientific officer of Labcorp Diagnostics, was recognized by the Healthcare Bu... |
| 19.03.2021 | Labcorp Scheduled to Speak at KeyBanc Capital Markets' Life Sciences and MedTech Investor Forum | BURLINGTON, N.C.--(BUSINESS WIRE)--Mar 19, 2021--
Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at KeyBanc Capital Marke... |
| 09.03.2021 | Labcorp Named to Fast Company’s List of the World’s Most Innovative Companies for 2021 | BURLINGTON, N.C.--(BUSINESS WIRE)--Mar 9, 2021--
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has been named to Fast Company magazine’s list of 2021 Most Innovative Companies. Since 2008, the annual li... |
| 08.03.2021 | PathAI and Labcorp Broaden Strategic Collaboration to Accelerate Use of AI-Powered Pathology | BOSTON and BURLINGTON, N.C. (PRWEB) March 08, 2021
PathAI, a global provider of artificial intelligence-powered (AI-powered) technology for use in pathology research, and Labcorp (NYSE: LH), a leading global life sciences company, today ann... |
| 23.02.2021 | Labcorp is Scheduled to Speak at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference | BURLINGTON, N.C.--(BUSINESS WIRE)--Feb 23, 2021--
Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at Citi's 2021 Healthcar... |
| 13.01.2021 | Labcorp CEO says Covid vaccine recipients don’t need to be tested for antibodies afterward | Experts are not recommending that Covid vaccine recipients have an antibody test after they are vaccinated, Labcorp CEO Adam Schechter told CNBC on Tuesday.
“We still have to understand a lot more about the vaccines, know what to measure, h... |
| 20.10.2020 | LabCorp Launches Fully Integrated Clinical Trial Platform to Streamline Drug Development Process | What You Should Know:
– LabCorp launches fully integrated clinical trial platform to streamline the drug development process featuring
– The new clinical trial platform will deliver dramatic reductions in patient and study site administrati... |
| 13.08.2020 | Mission Bio Lands $70M to Expand Cancer Therapies With Single-Cell Multi-Omics Platform | What You Should Know:
– Mission Bio raises $70 million in Series C funding led by Novo Growth to accelerate the development of cancer therapies with single-cell multi-omics.
– Mission Bio’s Tapestri Platform, the first single-cell platform ... |
| 09.06.2020 | How Covid-19 is accelerating adoption of decentralized clinical trials | Late last month, one of the largest contract research organizations and its parent company announced a partnership with a technology company to promote adoption of virtual clinical trials. But an important subtext to the trend is what has h... |
| 09.06.2020 | Top 10 companies that have raised funding in the men's health space | While funding women's health startups is rising, men's health so far isn't seeing the same boost
Funding for women's health startups is on the rise after traditionally lagging behind. While that's a great thing, the same can't be said for s... |
| 21.04.2020 | LabCorp gets FDA authorization for its in-home COVID testing kits | The kits will be first available to healthcare workers, with plans for widely availability soon
The debate over whether or not the United States is ready to reopen or not really comes down to one thing: testing. Are we testing enough people... |
| 20.03.2020 | Covid-19 roundup: Italy death toll officially tops China; US company plans roll out of at-home specimen collection kits | In a first, China reported on Thursday that there were no new locally-transmitted coronavirus cases for the first time since the pandemic began, while President Trump implied treatments to fight the coronavirus scourge w... |
| 06.03.2020 | LabCorp launches coronavirus (COVID-19) testing | With media outlets reporting shortage of coronovirus test kit here in the U.S., it’s difficult to know the exact number of people infected with virus. Now there is a good news. LabCorp, a global life sciences and the world’s leading health ... |
| 05.03.2020 | Quest Diagnostics to start coronavirus testing Monday | “In times of national health crises, quality laboratory testing is absolutely critical to mobilizing effective public health response,” Quest Diagnostics CEO Steve Rusckowski said in a statement. “Quest’s national scale, diagnostic expertis... |
| 22.01.2020 | Quest Diagnostics acquires Blueprint Genetics | “The great challenge with genetic testing is generating quality, actionable and broadly accessible insights from vast quantities of sequenced genetic data,” Quest CEO Steve Rusckowski said in a statement. “Blueprint Genetics has developed a... |
| 12.09.2019 | Bayer trims 2 top execs, shrinks management board; SpringWorks boosts size of IPO | → After welcoming J&J dealmaker Marianne De Backer to their team as BD chief a little more than a week ago, Bayer announced that it will be reducing the size of the company’s board of management. Hartmut Klusik and Kem... |
| 28.09.2017 | Charting the growth in the reproductive health genetic testing market | But now there has been progress in different methods of reproductive genetic testing. For instance, a recent explosion of the utilization of additional non-invasive prenatal testing (NIPT), and the continuous expansion of upstream preconcep... |
| 31.07.2017 | Term Sheet — Monday, July 31 | GOING DIRECT
I’m back! Huge thanks to Polina Marinova, Jen Wieczner and Robert Hackett for filling in. Today I’m diving into direct listings.
Paid Content Securing the enterprise without boundaries From ExtraHop
The reality has been a bit… ... |
| 06.02.2017 | LabCorp reportedly planning $8B buyout of CRO | In an emailed statement, a LabCorp spokesperson said the company does not comment on market rumors.
It’s not the first time M&A negotiations have been leaked. In April 2016, Bloomberg reported that LabCorp was in talks to acquire INC Re... |
| 20.01.2016 | These are the key players in the home health testing market | Source: Kalorama Information
Direct-to-consumer laboratory testing is on the rise, as consumers become more educated and proactive about their own health. The market’s expected to grow past $350 million by 2020 – a significant increase over... |
| 21.11.2015 | In Defense Of Theranos | Micah Rosenbloom Contributor
Micah Rosenbloom is a venture partner at Founder Collective.
More posts by this contributor
How to prepare for an investment apocalypse
Business school grads and quants are winning the battle to create the next ... |
| 25.11.2014 | LabCorp, Envision lead $15 million investment in remote patient monitoring company Vivify Health | Plano, Texas-based remote patient monitoring company Vivify Health has raised the first tranche of funding in what the company expects to be a $15 million round. Strategic investors Laboratory Corporation of America Holdings (LabCorp) and E... |
| 13.08.2014 | Seventh Sense Biosystems Raises $16M in Series B Financing | Seventh Sense Biosystems, Inc., a Cambridge, MA-based developer of virtually painless blood collection and diagnostic platforms, raised $16m in Series B financing.
Backers included new investors the Venture Capital unit of Siemens Financial... |
| 07.05.2014 | Google Ventures Leads $130M Series B In Cancer Data Startup Flatiron Health | Flatiron Health, a startup that organizes real-time oncology data to help cancer patients and doctors, has raised $130 million in Series B funding led by Google Ventures, with participation from First Round Capital, Laboratory Corporation o... |
| 21.10.2013 | IROA Forms Florida Partnership, Pushes Metabolomics Forward | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Metabolomics, which is the study of the unique chemical imprints that specific cellular processes leave behind, in is an up-and-coming field in biotech, says Felice de Jong, c... |
| 22.07.2013 | SynapDx gets $15.4M to develop a blood test for autism | Medical technology startup SynapDx has earned the support of venture capitalists and geneticists alike, raising $15.4 million to develop a blood test for autism.
The Massachusetts-based research team behind SynapDx hopes to test children fo... |
| 22.07.2013 | Google Ventures Leads $15.4M Round in SynapDx to Advance Early Autism Test | After an already successful start to 2013, Lexington, Mass.-based SynapDx has announced Monday another $15.4 million round, this time led by Google Ventures.
The pediatric genomics startup’s founding funders North Bridge Venture Partners an... |
| 08.07.2013 | Molecular diagnostics company GeneCentric collects $2.5 million for cancer tests | A second platform, a 13-gene hypoxia signature, is under development to identify cancer patients who may respond to anti-angiogenesis inhibitors.
The advent of whole genome sequencing has driven many diagnostics companies to use gene signat... |
| 21.02.2013 | SynapDx Secures $2M in Funding | SynapDx Corporation, a Southborough, Mass.-based developer of diagnostic test designed to identify children with autism spectrum disorders (ASD) by age 36 months, secured $2m in funding from Laboratory Corporation of America® Holdings (NYSE... |
| 04.06.2012 | LabCorp builds up specialty testing unit with $241M MEDTOX acquisition | LabCorp has made a concerted effort to grow by acquisition with a particular emphasis on specialty testing. Such tests include tests for infectious diseases, endocrinology, genetics, oncology and clinical trials. Through the end of 2011, La... |
| 11.04.2012 | Quest Diagnostics announces new CEO, gets approval for C difficile test | Philips Healthcare is the largest component of Royal Philips Electronics. Under Rusckowski’s tenure, sales in the Healthcare Division rose from $8.6 billion (€6.6 billion) in 2007 to $11.7 billion (€8.9 billion) in 2011. Last year, the comp... |
| 05.04.2012 | LabCorp strikes deal for Alzheimer’s disease diagnostic | Alzheimer’s disease affects more than 5 million people in the United States and more than 35 million worldwide. There are no specific tests available to detect Alzheimer’s disease and track its progression. Diagnosis is currently conducted ... |
| 30.03.2012 | Personalized medicine’s promise and challenges discussed at Duke forum | Green was among the speakers at a March 29 personalized medicine symposium at Duke University. Duke’s Center for Personalized Medicine coordinated the program entitled “At the Interface of Clinical Research and Clinical Medicine.” The sympo... |
| 16.12.2011 | LabCorp completes $85M acquisition of Orchid Cellmark | Burlington, North Carolina-based LabCorp’s pursuit of Orchid dates to 2008. In September of that year, LabCorp sent an unsolicited, nonbinding indication of interest to acquire all of the Princeton, New Jersey company’s outstanding stock, a... |
| 12.12.2011 | LabCorp completes ORCH offer, extends deadline for remaining shares | LabCorp in April announced it would acquire Orchid in a deal to boost its identity testing offerings and give the company a presence in the United Kingdom, where Orchid already has operations. The deal was expected to close in May but the F... |
| 08.12.2011 | LabCorp gets FTC OK for $85M Orchid acquisition | The agreement with the FTC comes eight months after Burlington, North Carolina-based LabCorp announced it would acquire Orchid. The deal was intended to bolster LabCorp’s identity testing offerings while also giving the company a presence i... |
| 18.11.2011 | Personalized medicine’s opportunities and challenges for clinicians, business | Not all personalized medicine drugs and diagnostics will have such a speedy path through the FDA. But the companies, academics and investors who have a stake in personalized medicine are working to smooth the path for future personalized me... |
| 20.09.2011 | Cancer diagnostics firm GeneCentric raises $250,000 | Perou and Hayes are already working together on genomic cancer research. The two are leading a team of UNC researchers supported by a Cancer Genome Atlas Grant. In August, UNC was named as one of 12 research centers participating in the eff... |
| 10.08.2011 | LabCorp partners with DHMRI to develop clinical research tests | Financial terms of the deal were not disclosed. But the agreement provides commercialization path for companion diagnostics and other tests once they’ve been validated in a clinical setting.
The DHMRI was founded businessman David H. Murdoc... |
| 18.07.2011 | LabCorp’s $85M Orchid offer extended again; FTC continues its review of deal | LabCorp provides laboratory services nationwide through its network of more than 1,500 labs. But the company has said that it wants to generate more of its revenue from specialty tests. Orchid would also help with LabCorp’s ambitions for in... |
| 12.07.2011 | Solstas acquires two N.C. lab services firms; eyes more M&A in next month | “We expect to close a couple more transactions within the next 30 days that will continue to expand our coverage and geographic area,” Bud Thompson, Solstas’s executive vice president, told MedCity News.
The Wilmington deals follow the June... |
| 16.06.2011 | LabCorp offer to buy Orchid extended to July 15; FTC still reviewing deal | LabCorp‘s (NYSE:LH) deadline to buy DNA testing services firm Orchid Cellmark (NASDAQ:ORCH) has been extended to July 15, the third extension for the deal in the last month.
The Burlington, North Carolina-based diagnostics and laboratory se... |
| 06.04.2011 | DNA testing company Orchid to be acquired by LabCorp for $85M | Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth ... |
| 20.07.2009 | Wellness predictor Allostatix hopes to be military’s PTSD detector | Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev... |
| - | LabCorp strikes deal for Alzheimer’s disease diagnostic | LabCorp (NYSE:LH) has struck a deal to develop and commercialize a new Alzheimer’s disease diagnostic.
The Burlington, North Carolina lab services and diagnostics company has licensed rights to an Alzheimer’s diagnostic technology from OPKO... |
| - | FDA authorizes Labcorp’s at-home test kit for Covid-19, flu | Pixel received emergency use authorization for an at-home combined Covid-19 and flu test kit. Credit: Labcorp
The Food and Drug Administration gave the green light to Labcorp’s at-home combination test for Covid-19 and influenza A and B. Th... |
| - | Solstas acquires two N.C. lab services firms; eyes more M&A in next month | Laboratory testing firm Solstas Lab Partners is sating its acquisition appetite with more deals, this time acquiring two lab firms in Wilmington, North Carolina.
Nextwave Diagnostic Laboratories and Wilmington Pathology Laboratory represent... |
| - | These are the key players in the home health testing market | Source: Kalorama Information
Direct-to-consumer laboratory testing is on the rise, as consumers become more educated and proactive about their own health. The market’s expected to grow past $350 million by 2020 – a significant increase over... |
| - | Why This Monk-Turned-Entrepreneur Is Betting His NFT Lounge Can Survive the FTX Fallout | Set in the foothills of Eastern Malibu across the street from Robert de Niro’s Nobu, the Rafi Lounge, a NFT-powered wellness center and coworking space, somehow looks like both a beachfront country club and a swank monastery. On a clear day... |
| - | LabCorp partners with DHMRI to develop clinical research tests | LabCorp (NYSE:LH) will work with the David H. Murdock Research Institute to develop new testing tools that could be used in clinical research worldwide.
Under the partnership with the DHMRI announced Wednesday, LabCorp’s clinical trials div... |
| - | Personalized medicine’s opportunities and challenges for clinicians, business | Perhaps the biggest personalized medicine breakthrough of 2011 was the progress of melanoma drug Zelboraf and its companion diagnostic, both of which sped through regulatory approval.
Clinical trials demonstrated that Roche‘s (OTC:RHHBY) Ze... |
| - | Wellness predictor Allostatix hopes to be military’s PTSD detector | CINCINNATI, Ohio — The wellness company Allostatix has struggled to find a foothold selling Corporate America on the idea that its blood test can act as an early warning system for employee health problems.
Now, it’s hoping to make a deal w... |
| - | Molecular diagnostics company GeneCentric collects $2.5 million for cancer tests | Using the genetic properties of tumors to classify them more specifically and determine whether they may respond to anti-angiogenic drugs has netted a two-year-old diagnostics firm a $2.5 million round.
GeneCentric Diagnostics Inc. is now a... |
| - | LabCorp reportedly planning $8B buyout of CRO | Burlington, North Carolina-based LabCorp is rumored to be negotiating an $8 billion acquisition of Pharmaceutical Product Development (PPD), a global contract research organization operating in over 50 countries.
Reuters broke the story on ... |
